F rom previous histopathologic studies, it is known that atherosclerotic lesions share many features with those of inflamed tissues. The causes of inflammatory reactions in the vessel wall, however, are still under discussion. Several hypotheses have been proposed, including the theory of infection as a cause of coronary artery diseases, which was first described by Osler 1 at the beginning of this century. Although there is now a growing body of evidence suggesting an association between infections and atherosclerosis, the mechanism by which microbial pathogens may act in a proatherogenic manner is still unresolved.
In a previous study, we identified the expression of a secretory phospholipase A 2 (sPLA 2 ), which is identical to group IIA isozyme (sPLA 2 -IIA) according to the new group type classification of phospholipases A 2 proposed by Dennis 2 and Murakami et al, 3 in human atherosclerotic plaques but not in normal arteries. 4 From in vitro studies, it is known that phospholipase A 2 can hydrolyze the phospholipids of lipoproteins, resulting in varied physicochemical properties of modified particles. 5, 6 These alterations apparently lead to an enhanced degradation of modified lipoproteins by macrophages, transforming them into foam cells, a hallmark of early atherosclerotic lesions. 7, 8 These data led to the hypothesis that sPLA 2 could be a new factor in the pathogenesis of atherosclerosis. 9 In recent years, further studies have been published involving the analysis of sPLA 2 expression in human vascular tissues. 10 -14 Bobryshev et al 10 performed a study on carotid arteries and aortas and found sPLA 2 -specific immunostaining in atherosclerotic plaques but not in areas of the adjacent normal-appearing arterial wall. Another 2 studies have been published by Hurt-Camejo et al 11 and Elinder et al, 12 respectively, showing sPLA 2 immunoreactivities not only in atherosclerotic arteries but also in nonatherosclerotic arteries.
The physiological and/or pathophysiological relevance of sPLA 2 expression in arterial tissues remains to be elucidated. In vitro studies indicated a substrate preference of sPLA 2 for Gram-negative bacterial membranes, such as from Escherichia coli, in the presence of bactericidal/permeabilityincreasing protein. 15 Recently, bactericidal activity of sPLA 2 against Gram-positive bacteria has been observed in human tears. 16 Based on these data, which suggest microbicidal properties of sPLA 2 , the question arises of whether the expression of sPLA 2 in atherosclerotic lesions could represent a part of the host defense mechanism against microbial pathogens. This assumption was supported by further in vitro and in vivo data showing that (1) the synthesis and secretion of proinflammatory cytokines, including interleukin (IL)-1␤, tumor necrosis factor-␣ (TNF-␣), and interferon-␥ (IFN-␥), are induced after exposure to bacterial endotoxins 17, 18 ; (2) cytokines such as IL-1␤, IL-6, and TNF-␣ are able to stimulate the synthesis and secretion of sPLA 2 in smooth muscle cells 19, 20 ; and (3) proinflammatory cytokines are expressed in atherosclerotic plaques. 21 The objective of the present study was to investigate the expression of sPLA 2 -IIA in relation to the stage of atherosclerosis and the presence of microbial agents and signs of inflammatory reactions in human vascular walls. For this purpose, abdominal and thoracic aortic segments obtained at autopsy after sudden death were analyzed by immunohistochemistry, polymerase chain reaction (PCR), and reverse transcription (RT)-PCR methods.
Methods Tissues
Human arterial samples (nϭ102) obtained at autopsy from 51 persons (38 males and 13 females ranging in age from 1 to 94 years, meanϮSEM 41.7Ϯ17.1 years) were taken from 2 cm above the aortic valve and 3 cm below the renal ostia, respectively. To exclude positive results concerning the expression of proinflammatory cytokines and sPLA 2 -IIA mediated by acute-phase reaction, the tissues were taken from subjects whose death was sudden and who did not show signs of severe acute diseases. Most common causes of death were accidents, homicides, or suicides. The time between death and autopsy, during which the subjects were kept at 4°C, ranged from a few hours to 6 days.
Histopathology and Immunohistochemistry
Immediately after autopsy, the removed aortic segments were washed in PBS (pH 7.2), fixed in neutral-buffered formalin, and embedded in paraffin. Subsequently, the samples were coded, and all further investigations were performed with observers blinded to the details of the study protocol. To determine the stage of atherosclerosis, sections were stained by hematoxylin-eosin staining. Goldner's trichrome staining was applied to visualize extracellular components. The immunohistochemical investigations were performed as described elsewhere 4 by applying the biotin-streptavidin-alkaline phosphatase system (Super Sensitive Multilink, Biogenex). Before incubation with specific antibodies, deparaffinized and rehydrated sections were treated with 0.5 mg/mL Pronase (DAKO Diagnostica) for 15 minutes at 24°C. To detect antigens, serial sections were incubated with monoclonal antibodies recognizing (1) human sPLA 2 (BIOMOL), (2) ␣-actin from smooth muscle cells (DAKO Diagnostica), and (3) CD68 from macrophages (clone KP-1, DAKO Diagnostica). The monoclonal anti-sPLA 2 antibody, prepared originally against the sPLA 2 from human sperm, cross-reacts immunologically with the sPLA 2 enzyme expressed in atherosclerotic plaques, as previously demonstrated. 4 The immunoreactivities were visualized by Fast Red TR as chromogen containing levamisole to block endogenous alkaline phosphatase activity (Biogenex). In each case, nonimmune mouse serum instead of specific antibodies was used as a negative control. Prostate tissue processed in the same way as aortic tissues after autopsy was used as a positive control because of the known sPLA 2 -positive immunoreactivities in glandular epithelial cells of this tissue. 22 The score of sPLA 2 -IIA immunostaining was assessed in the whole area of each section by using the following grades: 3ϩ, intense immunoreactivity in numerous cells; 2ϩ, positive immunoreactivity in a moderate number of cells (10 to 100 cells); 1ϩ, weak immunoreactivity in a few cells; and 0, no immunoreactivity. Macrophage infiltrates were expressed as follows: 3ϩ, massive infiltration of macrophages; 2ϩ, moderate number of cells (10 to 100 cells); 1ϩ, only a few cells; and 0, no cells. The stages of atherosclerosis were classified according to the recommendations made by Stary et al. 23 Identification of Nucleic Acids Specific for C pneumoniae, H pylori, CMV, and HSV Nucleic acids from paraffin-embedded aortic sections (10ϫ5 mthick sections) were prepared by using the DNA isolation kit Puregene (Gentra Systems). For amplification of genomic DNA specific for Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus (CMV), and herpes simplex virus (HSV), primer pairs were applied as described 24 -27 (Table 1) . The buffers and reagents used in the PCR were those supplied in the Gene Amp Kit (Perkin-Elmer, ABI). The conditions of PCR were as follows: an initial denaturing step for 2 minutes at 94°C; 35 cycles at 94°C for 30 seconds, 62°C for 30 seconds, and 72°C for 1 minute; and, finally, an extension step at 72°C for 10 minutes (with the exception of H pylori, for which 62°C was applied in the extension step). The products of amplification were analyzed on ethidium bromide-stained 2% agarose gels under UV light. In cases of negative results, amplified samples were reamplified by a second PCR under the same condition as applied in the first PCR. Tissues that showed negative results after the second amplification were defined as pathogen-free specimens.
To verify the efficiency of DNA isolation and amplification, genomic DNA specific for pyruvate dehydrogenase was determined in parallel with the microbial pathogens in every aortic specimen. PCR reagents without templates and with nucleic acids isolated from C pneumoniae, H pylori, CMV, and HSV were used as negative and positive controls, respectively. The C pneumoniae prototype strain TW-183 and H pylori were kindly provided by Dr Pressler (Friedrich-Schiller-University, Jena, Germany). CMV and HSV of type 1 were obtained from Dr Wischmann (Technical University, Dresden, Germany). Isolated DNA from HSV of type 2 was purchased from Advanced Biotechnology. At the beginning of the present study, investigations on DNA from HSV of type 1 and type 2 proved the specificity of applied primers to identify both types of HSV.
Identification of mRNA Specific for sPLA 2 -IIA, IL-1␤, TNF-␣, and IFN-␥ To evaluate the stability of sPLA 2 -IIA mRNA in situ, 2 aortic segments obtained in surgery were analyzed after storage in humidified chambers at 4°C or 24°C for 1, 2, 4, 5, and 6 days before fixing. A segment of each biopsy was immediately fixed after the removal of tissues for use as a control. After they were embedded in paraffin, 5-m-thick and 10ϫ5-m-thick serial sections were prepared for immunohistochemical investigations and for extraction of RNA, respectively.
Total RNA was prepared after deparaffinization and rehydration from 10ϫ5-m-thick autopsy sections by acid guanidinium thiocyanate-phenol-chloroform extraction as described by Chomczynski and Sacchi. 37 Isolated RNA was converted to cDNA by using the GeneAmp RNA-PCR Kit (Perkin-Elmer). A portion of the RT reaction products was then amplified for identification of sPLA 2 -IIA and TNF-␣ mRNA by using nested PCR and identification of IL-1␤ and IFN-␥ mRNA by using conventional PCR. The applied primer pairs, which are respectively designed to span splicing sites between 2 exons, are summarized in Table 1 . For the analysis of sPLA 2 -IIA mRNA, oligonucleotides were synthesized according to the published nucleotide sequence of human placental sPLA 2 -IIA cDNA. 28 In the nested PCR, extrinsic and intrinsic primer pairs were applied in a final concentration of 0.1 mol/L and 0.8 mol/L, whereas in the conventional PCR, the final concentration averaged 0.8 mol/L. The conditions for amplification were as follows: 15 cycles at 94°C for 30 seconds and at 60°C for 50 seconds, followed by 40 cycles at 94°C for 30 seconds and at 72°C for 1 minute. The buffers and reagents used were the same as supplied in the GeneAmp Kit (Perkin-Elmer). After amplification, products were analyzed by electrophoresis on agarose gels. As control, GAPDH mRNA was determined in every autopsy sample.
Statistical Analysis
The prevalence of the expression of sPLA 2 in relation to the stage of atherosclerosis in aortic tissue and data from aortic specimens with and without the analyzed microbial agents were analyzed by using the 2 test and, if the expected frequencies were low, by the Fisher exact test. The confidence intervals for odds ratios were determined by using the Cornfield method. The Student t test was used to compare the average age of individuals positive and negative for C pneumoniae, CMV, or HSV.
Results

Identification of Microbial Agents in Autopsy Aortas
By use of PCR, 18 of the 102 tissue samples investigated showed the presence of DNA fragments of C pneumoniae, CMV, or HSV (Table 2 ). In 5 individuals, nucleic acids of C pneumoniae were found in both sections of the aorta, whereas in 8 individuals, microorganisms were found to occur in only 1 location, ie, either in the abdominal or the thoracic aorta. Samples with early signs of atherosclerotic changes (types I and II) or preatheromas (type III) were found to be up to 8.5% positive for analyzed microorganisms, whereas the tissues with advanced atherosclerotic lesions (types IV to VI) yielded up to 36% microbial agents. Tissue samples without atherosclerotic lesions were free of analyzed microorganisms (Table 3) . Genomic DNA of H pylori was not observed in any of the tissues investigated.
Identification of sPLA 2 -IIA Expression and of Transcripts Specific for Proinflammatory Cytokines in Autopsy Aortas
Preliminary investigation of 2 arterial tissue samples obtained during surgery showed that sPLA 2 -IIA and GAPDH mRNA were detectable by means of RT-PCR up to 4 days after removal of the tissue, provided the samples were stored at 4°C before fixing. After the day 5, there was a reduction of mRNA, and on day 6, no mRNA specific for sPLA 2 -IIA and GAPDH could be determined ( Figure 1A ). Compared with tissue samples stored at 4°C, the tissue samples stored at 24°C before fixing exhibited an accelerated decomposition of the * Compared with those in reference, primers were elongated by addition of 6 and 7 specific nucleotides. †In addition to specific target sequence, primers were elongated by addition of nucleotides leading to concatamers for other reasons.
sPLA 2 -IIA and GAPDH mRNA ( Figure 1A ). In contrast to mRNA, however, the immunohistochemical identification of sPLA 2 -IIA was not significantly impaired by unfixed storage up to 6 days after the intraoperative release of tissue. Furthermore, no differences in the intensity of sPLA 2 -IIA immunostainings were observed in aortas fixed in Bouin's solution, ethanol, or formalin (not shown).
All the autopsy aortic samples in which DNA sequences of pathogens were identified exhibited immunostaining and transcripts specific for sPLA 2 -IIA. The distributions and intensities of the sPLA 2 -IIA immunostaining and macrophage infiltrates in the individual vessel layers of the aorta are shown in Table 2 . It can be seen that along with the intima, the adventitia also exhibited sPLA 2 -IIA immunostainings. In 5 samples, the media was specifically stained for sPLA 2 -IIA. Transcripts of IL-1␤, TNF-␣, or IFN-␥ were identified in 11 of the 18 pathogen-positive tissues. In addition, macrophage infiltration was found in the intima and, with the exception of 1 sample, in the adventitia as well (Table 2) .
Together with the tissues in which pathogens were detected, a further 61 samples in which no DNA of the investigated microorganisms occurred revealed sPLA 2 -IIAspecific immunostaining. Of these samples, 52 simultaneously exhibited sPLA 2 -IIA-specific transcripts. Of the 52 samples, in which sPLA 2 -IIA expression was determined both on the protein level and on the mRNA level, 16 samples yielded transcripts of proinflammatory cytokines. All samples without sPLA 2 -IIA expression at the protein and the mRNA levels (nϭ23) contained none of the investigated pathogens and were also free of transcripts of IL-1␤, TNF-␣, and IFN-␥. Some of the results of these PCR and RT-PCR investigations are shown in Figure 1B . 
Immunostaining scores are defined in Methods. The stage of atherosclerosis was classified according to the recommendation published by Stary et al. 23 ϩ indicates presence; Ϫ, absence. 
The causes of death were homicide (case 1), accidents (cases 2, 3, and 5), and carbon monoxide intoxication (case 4). Immunostaining scores are defined in Methods. ϩ indicates presence; Ϫ, absence. Table 4 shows the frequency of sPLA 2 -IIA expression as a function of the stage of atherosclerosis in the autopsy tissues. Because no significant differences concerning the stagedependent enzyme expression between thoracic and abdominal sections of the aorta were apparent by multivariate analysis (not shown), the data of both segments were considered together. In Table 5 , the results of the univariate analysis are summarized. A significant association could be established between the presence of C pneumoniae, CMV, or HSV DNA sequences and the expression of proinflammatory cytokines and sPLA 2 -IIA transcripts. Furthermore, CD68-positive cell infiltrates and sPLA 2 -IIA immunostainings were more frequently detectable in the adventitia of aortas with microbial agents compared with specimens free of agents.
Immunohistochemical Examinations of Autopsy Aortas
Immunostainings specific for sPLA 2 -IIA and macrophage infiltrations were found in all 3 layers of pathogen-positive vessel walls. In Figure 2 , an abdominal aorta is shown that contained DNA of C pneumoniae ( Figure 1B, lane 11) ; it exhibited atheromatous lesions of type V. Strong positive sPLA 2 -IIA immunostainings were detectable in the lipid core, especially at the base of lipid core adjacent to the media (Figure 2A) . By use of serial sections ( Figures 2B through  2D) , the positive immunostainings were shown to correspond to CD68-positive macrophages. In addition to sPLA 2 -IIApositive signals in lipid cores, further immunostainings were evident in the media near the adventitia ( Figure 2B ). The sPLA 2 -IIA-positive cells exhibited a spindle-shaped morphology and were positive for ␣-actin (Figures 2B and 2D) . Figure 3 shows serial sections from an abdominal aorta with advanced atherosclerotic plaques of type VI in which DNA of C pneumoniae, CMV, and HSV could simultaneously be identified ( Figure 1B, lane 1) . The plaque was characterized by 2 different lipid cores with a fibrotic cap overlay ( Figure 3A) . Within the fibrotic caps, especially between the lipid cores, heavy cell infiltrations were apparent, of which individual cells were identifiable as CD68-positive macrophages ( Figure 3B ). Furthermore, small blood vessels were visible, suggesting neovascularization. In addition to sPLA 2 -IIA immunostainings associated with macrophages, further stainings were observed in regions corresponding to ␣-actin-positive round cells (Figures 3C through 3F) .
A further property of specimens exhibiting nucleic acids of pathogens consisted in strong sPLA 2 -IIA immunostainings of the adventitia, which were accompanied by infiltrations of numerous CD68-positive macrophages. Figure 4A through 4C shows the adventitia of a thoracic aorta that was positive for CMV DNA, IL-1␤, and TNF-␣ mRNA ( Figure 1B , lane 8) and that exhibited atheromatous lesions of type IV. In addition to smooth muscle cells and CD68-positive macrophages, sPLA 2 -IIA-positive immunoreactions were associated with connective tissue cells and extracellular matrix structures of the adventitia. Compared with pathogen-positive specimens with atherosclerotic changes, the thoracic aorta shown in Figure 4D through 4F did not exhibit nucleic acids of analyzed microbial pathogens ( Figure 1, lane 2) and was free of microscopically observable atherosclerotic lesions. In this specimen obtained at autopsy from a 23-year-old man, no sPLA 2 -IIA immunostainings were evident in either the intima (not shown) or the media/adventitia ( Figure 4D ). These data were consistent with results obtained by RT-PCR analysis, demonstrating a complete absence of mRNA specific for sPLA 2 -IIA ( Figure 1B, lane 2) . Comparable data indicating the complete absence of sPLA 2 -IIA expressions were observed in an additional 4 nonatherosclerotic aortas (Table 3) .
Two aortic specimens, although entirely free of atherosclerotic lesions, exhibited transcripts specific for sPLA 2 -IIA. Figure 5 shows an aorta of a 7-year-old child who died after carbon monoxide poisoning. Strong sPLA 2 -IIA-positive immunostainings were detectable in the media corresponding to ␣-actin-positive smooth muscle cells. By use of RT-PCR, sPLA 2 -specific mRNA and transcripts specific for TNF-␣ and IFN-␥ were identifiable in this tissue (not shown). In addition, the adventitia was characterized by infiltration of numerous CD68-positive macrophages, which was not the case in the other sPLA 2 -IIA-free nonatherosclerotic specimens. Comparable findings were made in a further sample taken from a thoracic aorta of a 10-year-old boy who died after an accident (Table 3) .
Discussion
There is increasing evidence that inflammation and immunologic mechanisms play a major role in atherogenesis, but exactly what stimuli are responsible for the initiation of these reactions remains to be determined. In the present study, aortic specimens obtained at autopsy after sudden death were analyzed for the presence of microbial agents and the expression of sPLA 2 -IIA and proinflammatory cytokines. The data show that 14% of the analyzed specimens exhibited nucleic acid fragments specific for C pneumoniae, whereas 3% were positive either for CMV or for HSV. Recently, Maass et al 38 published a study demonstrating that 15% to 26% of analyzed specimens obtained from different vascular regions were positive for C pneumoniae DNA by using a nested PCR protocol. In aortic wall samples, the prevalence of C pneumoniae averaged 18%, a value that closely parallels the frequency observed in the present study. Compared with frequencies observed in other studies, the frequencies observed in the present study and in the study of Maass et al 38 are relatively low. This could be due to differences in the incidence of C pneumoniae infections, dependent on the respective geographic regions in which the studies were carried out. Another reason might be that many surgical samples were examined for the presence of C pneumoniae, from which it can be expected that the samples will show a preponderance of atherosclerotic lesions. If this is taken into account and the prevalence of C pneumoniae in aortas with advanced atherosclerotic lesions (types IV to VI) is determined, the data in the present study yield a value of 31%. Indications of the occurrence of H pylori in aortic tissues could not be found in the present study, which is consistent with results published by Blasi et al. 39 To determine whether the presence of bacteria or viruses is accompanied by inflammatory reactions, markers of inflammatory activities such as infiltrates of CD68-positive macrophages and expressions of proinflammatory cytokines and sPLA 2 -IIA were investigated. In the present study, it was determined that all of the tissue samples in which genomic DNA of pathogens was found had strong macrophage infiltrates and sPLA 2 -IIA immunostainings in the intima and in the adventitia. Furthermore, in 11 of these specimens, transcripts specific for IL-1␤, TNF-␣, or IFN-␥ could be identified, which is significantly more frequent (PϽ0.001) than in specimens free of C pneumoniae, CMV, or HSV DNA sequences. These results are in accord with in vitro data showing that the infection of mouse macrophages or human alveolar macrophages with C pneumoniae resulted, along with the generation of reactive oxygen species, in a dose-and time-dependent release of TNF-␣ and IL-1␤ into the culture supernatant. 40, 41 Similar results concerning the production of TNF-␣ and IL-1␤ were obtained in human peripheral blood mononuclear cells after infection with C pneumoniae. 42 In CMV-infected mononuclear cells, an elevated level of IL-1␤ activity was determined. 43 The reason that cytokine-specific transcripts were not found simultaneously in all pathogencontaining and sPLA 2 -IIA-positive tissues may, on the one hand, be due to the concentration of mRNA being too low. On the other hand, it is also possible that along with the cytokines IL-1␤, TNF-␣, and IFN-␥ investigated in the tissues examined, other proinflammatory mediators, such as IL-6, that can also induce sPLA 2 -IIA expression were present. 44 sPLA 2 -IIA is known to exhibit a highly alkaline pI, leading to a strongly positively charged protein under physiological conditions. 45, 46 For this reason, it can be assumed that the enzyme will interact with negatively charged proteoglycans and, for that reason, bind itself, independent of the location of synthesis, to cell surfaces and extracellular matrix structures and be able to remain there for extended periods of time, as recently analyzed by Romano et al. 13 Increased sPLA 2 -IIA activities in the vessel wall may act in a proatherogenic manner in different ways. Besides the direct cytotoxicity due to the hydrolysis of membrane phospholipids, through which the maintenance of plaque structures can be disturbed, and besides the generation of proinflammatory lipid mediators, including eicosanoids and platelet-activating factor, a series of indirect effects may be associated with the expression of sPLA 2 -IIA. Lysophosphatidylcholine, which is produced in the hydrolysis of phospholipids, was shown to exhibit cytolytic properties, 47 to induce the synthesis of heparin-binding epidermal growth factors through macrophages, 48 to express vascular cell adhesion molecules in endothelial cells, 49 and to be chemotactic for human monocytes 50 and T lymphocytes. 51 Furthermore, phospholipids of lipoproteins retained in the subendothelial space can be hydrolyzed by the enzyme identifiable at the same sites. It has been shown in vitro that the exposure of macrophages to LDL and HDL treated with phospholipase A 2 results in a considerable cholesterol accumulation in the cells, transforming macrophages into foamlike cells. 7, 8 In addition to the tissue sections containing nucleic acids of pathogens, sPLA 2 -IIA immunostaining could be found in tissues in which there was no indication of the presence of C pneumoniae, CMV, or HSV. The mechanisms that induced the sPLA 2 -IIA transcription in these tissues are still unexplained. A concomitant expression of proinflammatory cytokines in some of these aortas may suggest that other stimuli were present, possibly even other microorganisms. In this connection, it is noteworthy that in 5 pathogen-free, but sPLA 2 -IIA-positive sections, IFN-␥ mRNA was detectable. These data may suggest, at least in IFN-␥-positive tissues, that activated T lymphocytes were present, underscoring the occurrence of immunologic reactions in these specimens. The finding of a correlation between the prevalence of sPLA 2 -IIA expressions and the stage of atherosclerosis provided further evidence that the induction of the enzyme synthesis and secretion in the aortic wall may be of importance not only for the progress but also for the initiation of atherosclerotic processes. The immunohistochemical investigations demonstrated that sPLA 2 -IIA-positive immunoreactivities were present, especially in regions of lipid cores (primarily at the base of lipid cores adjacent to the media) and in areas of extracellular matrix structures. When the sPLA 2 -IIA and CD68-specific immunostainings are compared, the enzyme has never been identified in intima free of considerable numbers of macrophages. On the other hand, the presence of macrophages did not correlate strongly with sPLA 2 -IIA expression, in view of the fact that macrophage infiltrations with and without evidence of sPLA 2 -IIA were detectable, suggesting a different activation state of macrophages in atherosclerotic lesions, which is in accordance with data published by van der Wal. 52 Furthermore, a number of tissues have been found to exhibit adventitia, including the Figure 1B, lane 2) . Panels A and D were stained with anti-sPLA 2 -IIA antibodies; panels B and E were stained with anti-CD68 antibodies for macrophages; and panels C and F were stained with anti-␣-actin antibodies against smooth muscle cells. Mayer's hematoxylin counterstaining was used. Original magnification ϫ200. media half directed toward it, and to a lesser extent intima, which were positive for sPLA 2 -IIA. At the same time, massive infiltrations of CD68-positive macrophages were to be found in the adventitia of these tissues. Because sPLA 2 -IIA-specific immunostainings could be attributed, among other cellular and extracellular structures, to macrophages in the adventitia, the question arises as to whether inflammatory cells may initiate the induction of the sPLA 2 -IIA gene after they have entered the arterial wall not only from the vascular region but also from the adventitia via the vasa vasorum.
In addition to CD68-positive macrophages, ␣-actin-positive round cells associated with areas of plaque neovascularization and strong cell infiltrates were identified as sPLA 2 -IIA positive. The nature of these cells remains to be elucidated. Other ␣-actin-and sPLA 2 -IIA-positive cells frequently exhibited a typical stellate-shaped appearance. Recently, Tjurmin et al 53 have shown that stellate cells of myxomatous tissue represent a heterogeneous cell population, sharing features of macrophages, smooth muscle cells, and antigenpresenting dendritic cells. The latter cell type is characterized by immunoreactivity with antibodies recognizing ␣-actin, HLA-DR, and CD1a. 53 Bobryshev et al 10 have argued that in addition to macrophages, at least in part, vascular dendritic (CD1a-positive) cells may be responsible for the sPLA 2 -IIA expression in atherosclerotic plaques. These data suggest that in addition to CD68-positive macrophages, smooth muscle cells, and adventitial fibroblasts, stellate cells may be responsible for the expression of sPLA 2 -IIA identified in atherosclerotic lesions. Interestingly, Tjurmin et al 53 hypothesized that in atherosclerotic lesions, stellate cells might be involved in local immune responses, in which they act as antigen-presenting cells.
To understand the possible role of sPLA 2 -IIA in the pathogenesis of atherosclerosis, the determination of whether this enzyme is expressed in normal arteries is of major importance. In our previous study, sPLA 2 -IIA-positive immunostainings were visible in arterial and aortic specimens exhibiting atherosclerotic plaques but not in nonatherosclerotic aortas or nonaffected parts of the arterial wall. 4 Whereas Bobryshev et al 10 found these results to be confirmed in their studies, Hurt-Camejo et al 11 and Elinder et al 12 described sPLA 2 -IIA immunoreactivities both in normal nonatherosclerotic arteries and in those with atherosclerotic lesions. In the present study, 7 specimens were classified as nonatherosclerotic. Five of them showed neither sPLA 2 -IIA-specific immunostainings nor traces of sPLA 2 -IIA mRNA. Because of the significantly faster decomposition of sPLA 2 -IIA mRNA in removed aortic tissues after storage at 24°C compared with those at 4°C before fixing, the present study only considered autopsy samples taken from subjects who were delivered to the facility within a few hours of death and were kept at 4°C until autopsy. Furthermore, only those samples were evaluated in which GAPDH mRNA could be detected as a control. This applied also to the 5 sections classified as nonatherosclerotic. Finally, the preliminary investigations showed that when samples were stored at 4°C, sPLA 2 -IIA levels remained immunohistochemically unchanged up to 6 days post mortem, so that false negatives concerning the sPLA 2 -IIA immunostaining in the 5 nonatherosclerotic aortas and in further aortic specimens with early stages of atherosclerosis (nϭ18) can be ruled out.
In 2 nonatherosclerotic thoracic aortas, strong positive sPLA 2 -IIA immunostainings were evident. These findings were confirmed in both tissue samples by the detection of sPLA 2 -IIA-specific mRNA. The investigations of proinflammatory cytokines have shown, however, that both specimens simultaneously exhibited transcripts specific for TNF-␣ and IFN-␥ or IL-1␤ and IFN-␥, which was not the case in the other sPLA 2 -IIA-free nonatherosclerotic specimens. Such results point to inflammatory reactions as the possible cause of the sPLA 2 -IIA expressions observed in both samples, although the reason for the inflammation in these tissues is presently unexplained. Therefore, the different results concerning whether sPLA 2 -IIA is expressed in normal arterial sections 4,10 -13 are possibly explained with reference to whether inflammatory reactions were ongoing before the removal of tissues.
In summary, the present study has shown that the presence of microbial agents is closely associated with the expression of sPLA 2 -IIA and macrophage infiltrates in human aortic specimens. This finding strongly suggests that (1) the induction of the sPLA 2 -IIA gene in cells of the aortic wall can be considered a further indicator of ongoing inflammatory reactions in these tissues and (2) the expression of sPLA 2 -IIA may be a constituent of the host defense mechanism in vessel walls. Furthermore, because macrophages exposed to phospholipase A 2 -modified lipoproteins are transformed into foam cells in vitro, the present study provides evidence for a potential mechanism by which microbial infections may act in a proatherogenic manner. This mechanism is in accordance with the response-to-injury hypothesis of atherogenesis, which proposes that atherosclerotic lesions represent a specialized form of a protective inflammatory response to various forms of insults to the vessel wall. 54 In the progression of this response, a set of proinflammatory cytokines including IL-1␤, TNF-␣, and IFN-␥ may be released by inflammatory cell infiltrates, which in turn induce the synthesis and secretion of sPLA 2 -IIA. However, when infectious agents persist in the arterial wall, the expression of sPLA 2 -IIA, possibly triggered as a protective response to microbial invasions, may become excessive. In addition to a series of pathophysiological reactions propagating inflammatory processes in the arterial wall, chronically increased sPLA 2 -IIA activities may be associated with the hydrolysis of lipoprotein phospholipids. Thereby, the process of foam-cell formation can be forced, especially when high concentrations of lipoproteins are simultaneously present in the subendothelium of the vessel wall. Interestingly, a recently published study involving mice with LDL receptor deficiency provided evidence that the chlamydial proatherogenic effects are dependent on elevated serum cholesterol levels. 55 Although native lipoproteins proved to be a poor substrate for sPLA 2 -IIA, an increased susceptibility of lipoproteins to phospholipid hydrolysis after minimal oxidation, which is especially likely to occur under inflammatory conditions in vivo, could recently be shown. 56 This mechanism, if proven in vivo, may inaugurate an alternative strategy for prevention and therapy of coronary artery disease by applying specific sPLA 2 -IIA inhibitors.
